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Abstract Autism spectrum disorder (ASD) is one of the
most prevalent neurodevelopmental disorders with high her-
itability, yet a majority of genetic contribution to pathophys-
iology is not known. Siblings of individuals with ASD are at
increased risk for ASD and autistic traits, but the genetic
contribution for simplex families is estimated to be less
when compared to multiplex families. To explore the ge-
nomic (dis-) similarity between proband and unaffected
sibling in simplex families, we used genome-wide gene
expression profiles of blood from 20 proband-unaffected
sibling pairs and 18 unrelated control individuals. The glob-
al gene expression profiles of unaffected siblings were
more similar to those from probands as they shared genetic
and environmental background. A total of 189 genes were
significantly differentially expressed between proband-sib
pairs (nominal p<0.01) after controlling for age, sex, and
family effects. Probands and siblings were distinguished
into two groups by cluster analysis with these genes.
Overall, unaffected siblings were equally distant from the
centroid of probands and from that of unrelated controls
with the differentially expressed genes. Interestingly, five
of 20 siblings had gene expression profiles that were more
similar to unrelated controls than to their matched probands.
In summary, we found a set of genes that distinguished
probands from the unaffected siblings, and a subgroup of
unaffected siblings who were more similar to probands. The
pathways that characterized probands compared to siblings
using peripheral blood gene expression profiles were the up-
regulation of ribosomal, spliceosomal, and mitochondrial
pathways, and the down-regulation of neuroreceptor-
ligand, immune response and calcium signaling pathways.
Further integrative study with structural genetic variations
such as de novo mutations, rare variants, and copy number
variations would clarify whether these transcriptomic
changes are structural or environmental in origin.
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Introduction
Autism spectrum disorders (ASD) comprise a group of neuro-
developmental disorders with high heritability. An increased
risk for siblings and twins has been well reported in previous
studies; however, the genetics of ASD has become increas-
ingly complex from genome-wide association, linkage analy-
sis, copy number variation (CNV), and whole-genome and -
exome sequencing studies [1–4]. Altogether, the genetic
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contribution from known de novo mutations, single nucleo-
tide polymorphisms (SNPs) and CNVs explains no more than
20 % of cases. Moreover, shared environmental effects seem
to play a more significant role in co-morbid fraternal twins
compared to genetic factors [5].
The sibling recurrence risk of autism has been esti-
mated to be between 3 % and 10 % [6, 7], and a recent
prospective study revealed that the sibling recurrence rate
of ASD is higher than suggested by previous estimates
[5]. In that study, a total of 18.7 % of infant siblings
developed ASD. Specifically, male gender and presence
of at least one affected sibling were independent and
significant predictors of an ASD outcome, with a 2.8-
fold increase in the risk for ASD for male infants com-
pared to female infants from simplex families (families
with only one affected child, and unaffected parents and
siblings) and an additional 2.2-fold increase for all chil-
dren, regardless of gender, in multiplex families (families
with more than one affected child, and unaffected parents
and siblings) [8].
Phenotypically, autistic traits and endophenotypes of
ASD are more frequently observed in unaffected siblings
and parents of children with ASD in simplex families
than in the unrelated control population [9–11]. Together
with recent results from CNV and exome sequencing
studies showing an increase in the rate of gene disrupting
de novo mutation in probands compared to their unaf-
fected siblings in simplex families [12–14], this has led
to a genetic model of ASD risk that posits the combina-
torial effect of common and rare variants including de
novo CNVs and mutations [15]. In this model, common
variants constitute genetic background that is shared in
unaffected siblings and relatives, and de novo genetic
events or environmental effects trigger the pathophysiol-
ogy of ASD. Importantly, this model allows for a spec-
trum of ASD phenotypes in relatives due to the contribution of
common variants.
Gene expression studies using peripheral blood cells
and lymphoblastic cell lines have shown that genome-
wide gene expression profiles differ between ASD cases
and non-cases [16–23], suggesting transcriptomic signa-
tures from peripheral blood could be used as a surrogate
for understanding the genetics of ASD. To this end, we
recently reported that a blood-based gene expression
signature was able to classify the males with ASD from
unrelated controls with greater than 70 % of accuracy in
two independently collected cohorts [16]. Glatt and col-
leagues [17] reported a transcriptomic diagnostic signa-
ture of ASD compared to typically developing children
using peripheral blood mononuclear cells. Luo and col-
leagues [1] found that outlier expression levels from
lymphoblastic cell lines were highly correlated with
structural genomic changes such as CNVs, but did not
find significant differences in overall numbers of outlier
genes between simplex cases and unaffected siblings.
Based on the above evidence, we explored whether pro-
bands have a different functional genomic signature that
is a snapshot of the combined effect of genetic and
environmental factors compared to their unaffected sib-
lings. We used peripheral blood gene expression profiles
of the probands and unaffected siblings from the Simons
Simplex Collection (SSC) to explore the (dis-) similarity
of probands and siblings compared to unrelated controls,
and to identify what genes and pathways differentiate
probands from their unaffected siblings.
Materials and methods
Probands and siblings from the Simons Simplex Collection
Blood samples of 20 probands and their unaffected sib-
ling pairs were collected from the SSC (Table 1). Five
proband-sib pairs were of the same gender, i.e., males,
while 15 pairs were of the opposite gender including 12
male and three female probands. These blood samples
were prepared for genome-wide gene expression profil-
ing using microarrays in one batch to minimize batch
effects. The age range was 4.1–17 years (mean age
10.15 years) in probands and 6–17 years (mean age
10.96 years) in unaffected siblings, and there was no
significant difference in age distribution between the
two groups (paired t-test, p=0.36). All subjects were
evaluated at Boston Children’s Hospital and probands
were diagnosed upon Autism Diagnostic Observation
Schedule and Autism Diagnostic Interview Revised data
according to the SSC criteria. No known genetic or
syndromic disorders were described in these individuals.
Blood samples from 18 individuals (11 males and seven
females) unrelated to the SSC proband-sibling families
were enrolled in this study as controls (Table 1). The age
ranged from 4.1 to 16.1 years (mean age 9.69 years) and
there was no significant difference in age distribution
compared to probands or sibs. These control samples
were collected from healthy patients seen in Children’s
Hospital Primary Care Center for a well child visit who
had a routine blood draw. Gene expression profiling of
these blood samples were processed in a different batch
from the SSC samples. If the child had a chronic disease
such as infectious disease, diabetes, cardiovascular dis-
ease, and developmental disorder or neurological disor-
der, they were excluded from this study. A male control
individual had a history of delayed speech; however, he
did not meet the diagnostic criteria of any language
disorders. All SSC participants and control individuals
were recruited with Institutional Review Board approval.
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Genome-wide gene expression profiling with microarrays
Gene expression profiles were prepared using Affymetrix
Gene 1.0 ST (GeneST) arrays (Affymetrix, California). Total
RNAwas extracted from 2.5 ml of whole venous blood using
the PAXgene Blood RNA System (PreAnalytix) according to
the manufacturer’s instructions. Quality and quantity of these
RNAs was assessed using the Nanodrop spectrophotometer
(Thermo Scientific) and Bioanalyzer System (Agilent).
Fragmented cRNA was hybridized to the appropriate
Affymetrix array and scanned on an Affymetrix GeneChip
scanner 3000.
Preprocessing of microarray data and statistical analysis
Gene expression levels were calculated using Affymetrix
Power Tools version 1.10 (Affymetrix). We used the Probe
Log Iterative ERror (PLIER) algorithm, and subsequent
normalization using a locally weighted scatterplot smooth-
ing (LOWESS) algorithm was performed to reduce the
variability between microarrays in two batches of SSC and
unrelated control samples. Differentially expressed genes
between probands and sib pairs were identified by fitting a
linear model for each probeset after controlling for age, sex,
and difference among families. We used the Storey–
Tibshirani’s method to estimated false discovery rates (FDRs)
for multiple hypothesis tests [24].
To explore global gene expression patterns across all sam-
ples, we applied a variance filtering to exclude probesets for
which expression levels were relatively consistent across all
samples.There were 8,326 probesets that had higher than 75
percentile of variance across all individuals. Using these pro-
besets, to measure similarity between the gene expression pro-
files from all individuals, the squared Mahalanobis distances
(MDs) from the centroid of probands and that of unrelated
controls were calculated for each sib with the pooled covariance
matrix estimated using cov.shrink function in the corpcor R
library [25]. We used the squared MDs as surrogates to quan-
titatively measure the similarity of sibs to probands and unre-
lated controls separately. Then, the distances from each centroid
were compared using a paired t-test. After identifying sub-
groups of proband-sibling pairs that were either similar or
divergent using unrelated controls as a benchmark, we per-
formed a series of paired and unpaired t-tests with unequal
variance to determine sets of differentially expressed genes.
Principal component analysis (PCA) of differentially expressed
genes was performed on centered (mean = 0) and scaled
(variance 1) expression values. Hierarchical clustering on dif-
ferentially expressed genes was performed with complete link-
age on Euclidean distance. To determine enriched pathways
among differentially expressed genes, we applied Gene Set
Enrichment Analysis (GSEA) [26]. With the exception of
GSEA, all statistical analyses were performed using the R
statistical programming language, version 2.15 (http://cran.r-
project.org/).
Results
Global gene expression patterns of probands, siblings,
and unrelated controls
PCA of 58 samples using all probesets showed no significant
batch effect or gender bias in global gene expression profiles
(Fig. S1); however, there was significant difference between
probands and the other groups. We calculated overall similar-
ity of gene expression patterns using the squared MD. Similar
to the PCA result, MDs from the common pooled centroid of
all 58 samples did not show any difference between groups;
however, the distribution of MDs from the centroid of pro-
bands and from that of unrelated controls revealed that the
probands, unaffected siblings, and unrelated controls formed
distinct clusters (Fig. 1). Unaffected siblings seemed to form a
separate cluster from that of probands when the centroid of
probands was used to calculate MD of each sample. Similarly,
the distribution ofMDs from the centroid of unrelated controls
showed that probands and siblings were similar relative to
Table 1 Clinical and demographic characteristics of 20 simplex fam-
ilies and 18 unrelated controls
Characteristic Probands Unaffected
siblings
Unrelated
controls
Number 20 20 18
Age (years)
Mean 10.2 11.0 9.7
Range 4.1–17.0 6.0–17.0 4.1–16.1
Gender
Male 17 8 11
Female 3 12 7
Race
White 20 20 3
Black 0 0 3
Other 0 0 12
Ethnicity
Hispanic 2 2 9
Non-Hispanic 18 18 9
Diagnosis
Autistic disorder 9 – –
PDD-NOS 11 – –
Developmental delays 0 4 1
Neurological disorders 0 1 0
Psychiatric disorders 4 1 0
Immune disorders 3 4 0
Gastrointestinal disorders 1 2 0
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unrelated controls. Together, these observations suggested a
difference between probands and siblings in gene expression
patterns, and we sought to find the genes that differentiated
probands from their unaffected siblings.
Differentially expressed genes in probands compared
to their unaffected siblings
We fit a linear model to the gene expression levels for each
probeset to prioritize consistently differentially expressed
genes between proband and sibling across SSC families
after controlling for age and sex. We used uncorrected p
values to prioritize significant genes since only one gene —
IL15RA — was significant at FDR <1 %. Among 269
differentially expressed genes between probands and sibs
significant at uncorrected p<0.01, there were genes signif-
icant by the other factors such as age (29 genes), gender (28
genes), and between families (35 genes) at the same signif-
icance level. After excluding the genes changed by these
other factors, 189 probesets that represent 163 unique genes
including two previously reported ASD candidate genes —
CTNNB1 and XPO1 — were significantly changed between
probands and siblings (uncorrected p<0.01) (Table S1).
Eighty-four probesets were up-regulated in probands com-
pared to unaffected siblings.
These 189 probesets were able to cluster probands and
siblings except for one sibling using hierarchical clustering
suggesting that these genes could be informative in classifying
probands from unaffected siblings (Fig. 2a). We further ex-
plored whether this clustering of probands was confounded by
the other factors such as gender and age. PCA of 20 proband-
sibling pairs with 189 probesets found probands and unaffect-
ed siblings were mostly separated by the first principal com-
ponent that explained 32.8 % of total variance (Fig. 2b). Age,
gender, and familial difference were not significantly correlat-
ed with any principal components. Thus, the gene expression
profile of 189 probesets was able to distinguish probands from
that of unaffected siblings.
Gene expression profiles reveal proband-like and control-
like siblings compared to probands
Previous studies report that the recurrence risk of ASD in
siblings could be as high as 10–20 % [27], and unaffected
siblings and relatives may have autistic traits [9–11]. However,
in simplex families, the prevalence of autistic phenotype in
unaffected siblings and parents is not yet known. We explored
whether a subgroup of unaffected siblings were similar to pro-
bands in transcriptomic changes compared to unrelated controls.
To estimate the similarity of global gene expression pro-
files between probands, unaffected siblings, and unrelated
controls, we calculated the multivariate distances of each
sibling with respect to the two centroids of probands and
unrelated controls clusters (see Materials and methods). The
unaffected siblings were more similar to probands overall
(paired t-test, p=0.052). However, as shown in Fig. 3a, five
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Fig. 1 Differences in global
gene expression profiles using
squared Mahalanobis distances
from the centroids of probands
and unrelated controls. Overall
gene expression profiles were
not different between probands,
siblings, and unrelated controls
by principal component analysis
(Fig. S1). We calculated a
multivariate distance, i.e.,
squared Mahalanobis distance
(MD), of each individual sample
from the centroid of unrelated
controls and that of probands.
The density plot on top of the
scatter plot shows that probands
and siblings are equally distant
from unrelated controls.
Interestingly, the distributions of
MDs from the centroid of
probands show significant
difference (p=6.6×10−9). This
result suggests that there seems
to be subtle but significant
difference in transcriptomic
signature between proband and
siblings
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unaffected siblings (green arrow heads) were more similar to
unrelated controls while the other 15 siblings were more
similar to probands or equidistant from proband and unrelated
control groups. We designated the 15 siblings that were closer
to probands as “proband-like” siblings (PLS), and the other
siblings as “control-like” siblings (CLS). Interestingly, CLS
individuals could be identified in the PCA plot using 189
probesets as they were located on the opposite side of probands
compared to PLS individuals (Fig. 3b). We tested whether the
difference between two sibling groups was due to the fact that
they were from different families by permuting the group
labels of the 20 siblings with replacement (permutation
B=10,000). At the same statistical significance threshold (un-
corrected p<0.01), the average number of differentially
expressed probesets between random groupings of unaffected
siblings into five and 15 was 316 (standard deviation (SD)
459.3, range 42–7,910). Thus, the differential expression of
3,126 probesets between PLS and CLS was significantly
greater than random expectation (permutation p=0.0056).
After classifying the 20 unaffected siblings into five CLS
and 15 PLS, we determined the differentially expressed genes
for the two comparisons (CLS vs. matched probands and PLS
vs. matched probands) by fitting linear models as described
above. The numbers of differentially expressed probesets for
these two comparisons were 513 and 269, respectively.
Compared to 189 significant probesets between 20 proband-
sibs pairs, overall numbers of significant ones were greater
after grouping CLS and PLS with their matched pairs
(Fig. 3c).PTPRC (protein tyrosine phosphatase, receptor type,
C) was differentially expressed between PLS and their
matched probands, and nine genes — CACNA1F, CDH22,
EN2, FOXG1, HTR1B, PRKD1, SETDB1, and XPC — were
significant between CLS and matched their probands among
the known ASD candidate genes in the Simons Foundation
Autism Research Initiative (SFARI) Gene 2.0 database (avail-
able at http://gene.sfari.org).
Remarkably, PCA of the union of these differentially
expressed genes (779 probesets total) revealed that CLS formed
a distinct cluster, whereas PLS overlapped with probands
(Fig. 3d).Taken together, these findings support the conclusion
that the 15 PLS individuals, as measured by comparing squared
MDs to probands and unrelated controls, approached the tran-
scriptomic signature of ASD, whereas the CLS were farther
from their matched probands in gene expression space.
Significant pathways between proband-like siblings
and probands
To identify the pathways that distinguish probands from their
unaffected siblings, we performed GSEA. GSEA ranks the
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pre-defined biological pathways by the concordant difference
between two groups across multiple genes in a pathway while
single-gene level change may not be significant. To facilitate a
meaningful biological interpretation, we tested only pathways
from the Kyoto Encyclopedia of Genes and Genomes (KEGG)
[28]. We found 13 KEGG pathways were significantly
changed in probands compared to unaffected siblings (nominal
p<0.01, corresponding FDR 0.34) (Fig. 4a). The positive
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normalized enrichment score (NES) in Table 2 represents that a
majority of genes in that pathway were up-regulated in pro-
bands compared to unaffected siblings. The two most signifi-
cantly up-regulated pathways in probands were ribosome and
spliceosome pathways. Seven pathways including neuroactive
ligand receptor interaction pathway, calcium signaling path-
way, and gap junction were down-regulated in probands.
In PLS vs. matched probands comparison, two immune
pathways were dysregulated in opposite directions. RIG-I-like
receptor signaling pathway describes the signaling pathways
that lead to the synthesis of type I interferon and other inflam-
matory cytokines in response to dsRNA due to viral replica-
tion in human cells, and chemokine signaling pathway
activates various downstream pathways such as cellular po-
larization and actin reorganization in response to chemokines.
In the matched probands of PLS group, RIG-I-like receptor
signaling pathway was up-regulated while chemokine signal-
ing pathway was down-regulated (Table S2).
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Fig. 4 Significant biological pathways between probands and siblings. a
KEGG pathways identified by GSEA for the three comparisons at nom-
inal p<0.01 (see Materials and methods) for the comparisons of probands
(prob) and siblings (sib), control-like siblings (cls) vs. matched prob,
proband-like siblings (pls) vs. matched prob, and pls vs. cls. The
pathways that are significant in any of four comparisons are listed and
red (up-regulated in prob or pls) and blue boxes (down-regulated) repre-
sent significantly changes. Ribosomal genes were consistently up-regu-
lated in all four comparisons (see Results). b TheVenn diagram shows the
overlap of significant pathways listed in panel a
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We found the smallest number of significant pathways
between PLS and matched probands. Ribosome pathway
was up-regulated in the other comparison — CLS vs.
matched probands, PLS vs. matched probands, and CLS
vs. PLS — while chemokine signaling pathway and endo-
cytosis were down-regulated in PLS vs. matched probands,
but not in the other comparisons (Fig. 4a). Interestingly, 27
pathways were found in both CLS vs. matched probands
and CLS vs. PLS comparisons (27/37 and 27/31 respective-
ly). The Venn diagram of significant pathways from three
comparisons suggested that CLS group seemed to be the
most different from PLS and probands overall (Fig. 4b).
Except for ribosome pathway, two overlapping pathways —
nucleotide excision repair and drug metabolism cytochrome
P450— changed to opposite directions. Oxidative phosphor-
ylation, Parkinson’s disease, and Huntington’s disease path-
ways all contained mitochondrial electron transport chain
(ETC) genes. Except for these pathways, all other pathways
had unique sets of genes that are specific for each pathway
(Table S3). By splitting probands into two groups of PLS
matched and CLS matched probands, we could identify addi-
tional interesting pathways such as long-term potentiation and
axon guidance that were down-regulated in probands com-
pared to matched CLS.
Discussion
The increased prevalence of ASD and autistic traits in rela-
tives of individuals with ASD is well established [8, 10] and is
likely due to, in part, shared genetic background of common
and rare variants that predispose for ASD [15]. Simplex cases
involve an increased de novo mutation rate and extent of de
novo CNVs, although support for this hypothesis is not con-
sistent across studies [2, 12, 14, 29–31] (reviewed by Berg and
Geschwind [15]). In this paper, we found the gene expression
signature of 189 genes that successfully distinguished pro-
bands from unaffected siblings. We also presented evidence
for variable similarity to probands across 20 siblings from
simplex families using blood gene expression profiling.
Comparison of 20 unaffected siblings to matched probands
and to 18 unrelated controls using squared MDs revealed that
15 were closer to probands (PLS), whereas five were closer to
unrelated controls (CLS).
Pathway analysis identified that ribosomal, spliceosomal,
and mitochondrial genes were up-regulated in PLS compared
CLS, and neuroactive ligand receptor interaction, ECM recep-
tor interaction, calcium signaling, and MODY (Maturity
Onset Diabetes of the Young) pathways were down-
regulated.Moreover, ribosomal and mitochondrial genes were
up-regulated in probands compared to CLS. Two immune
response pathways, RIG-I-like receptor signaling and chemo-
kine signaling pathways were changed to opposite direction in
probands compared to PLS. Immune pathways have been
implicated in ASD throughout multiple tissues. CNS cytopa-
thology [32], serum and CSF proteomics [33], a gene expres-
sion study using postmortem CNS tissue [34], and several
gene expression studies using LCL revealed a converging
signature of a perturbed immune system[21, 22]. Down-
regulation of calcium signaling pathway is interesting since
Table 2 Significant biological
pathways in probands compared
to unaffected siblings
Pathway Number of
genes
Normalized
enrichment score
Nominal p
value
False
discovery rate
Up-regulated in probands
Ribosome 78 2.46 0.00000 0.00000
Spliceosome 102 1.82 0.00064 0.08867
RIG-I-LIKE receptor signaling
pathway
63 1.81 0.00000 0.06492
Systematic Lupus Erythematosus 107 1.72 0.00128 0.11253
Oxidative Phosphorylation 104 1.68 0.00000 0.11198
RNA degradation 52 1.68 0.00644 0.09754
Down-regulated in probands
Neuroactive ligand receptor
pathway
257 −2.02 0.00000 0.00519
Maturity Onset Diabetes of the
Young (MODY)
24 −2.00 0.00000 0.00409
Arrhythmogenic right ventricular
cardiomyopathy
71 −1.84 0.00069 0.02690
ECM Receptor Interaction 78 −1.68 0.00136 0.11579
Gap Junction 78 −1.57 0.00814 0.27062
Calcium Signaling Pathway 171 −1.51 0.00561 0.24813
Regulation Of Actin Cytoskeleton 194 −1.42 0.00966 0.34729
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recent collaborative effort of meta-analysis of five major neu-
ropsychiatric disorders including ASD suggests that two cal-
cium channel coding genes — CACNA1C and CACNB2 —
are significantly associated with all five diseases [35].
Multiple independent studies also support the role of
mitochondrial function and pyrimidine metabolism in
ASD. Giulivi and colleagues [36] discovered a subgroup
of ASD with mtDNA CNVs and found that mitochondrial-
dependent oxygen consumption was impaired in peripheral
blood lymphocytes from children with autism compared
with control children. Anitha and colleagues [37] reported
that a group of mitochondrial ETC genes from Complex I–V
was down-regulated in post-mortem brains from patients
with ASD compared to controls. Moreover, functional brain
imaging studies using magnetic resonance spectroscopy also
found altered levels of ATP in ASD cases [38, 39].
There are potentially important limitations of the
current study. We did not focus on the differentially
expressed genes and pathways between unrelated con-
trols and simplex families due to two reasons. First,
families share environmental influences and most genet-
ic material, including material unrelated to ASD, so
siblings are better controls than unrelated individuals.
Second, though we tried our best to remove the batch
effect during microarray preparation, batch effects
remained between individuals from simplex families
and unrelated controls.The number of families and un-
related controls recruited for our current study was
limited as we analyzed the gene expression profiles
from 20 proband-sibling pairs and 18 unrelated controls.
We recruited simplex families and unrelated controls;
however, several studies have reported that subclinical
ASD phenotypes were more frequently observed in
multiplex families than in simplex families [10, 11].
Further investigation including multiplex families would
be an interesting direction.
To summarize, we explored peripheral blood gene
expression profiles from 20 children with ASD com-
pared with unaffected siblings. We asked two simple
questions: first, whether blood gene expression profiles
distinguish probands from unaffected siblings, and sec-
ond, what genes or pathways push unaffected siblings
towards probands. We successfully identified 189 genes
that could cluster probands and unaffected siblings into
two separated groups, and two groups of unaffected
siblings — PLS and CLS — using global gene expres-
sion patterns.The transcriptomic changes could be path-
ophysiologically linked or possibly reflect compensatory
changes. As we cannot draw any conclusion regarding
the causal relationship of these pathways to ASD, fur-
ther investigation using integrative analysis of whole-
genome or exome sequences with gene expression pro-
files including parents will be beneficial.
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